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Abstract: The M2 protein of the influenza A virus, responsible for flu, is a homotetramer transmembrane protein,
forming a transmembrane ion channel, where His 37s act as pH sensors and Trp 41s and Asp 44s act as channel gates.
Opening of this channel leads to transfer of virus RNA into the human host. Thus, blocking this transfer is an important
pharmaceutical strategy to stop infection. As a result of viral drug resistance, commercially available channel inhibitors,
rimantadine (RIM) and amantadine (AMA), are not as effective as they used to be. Understanding binding sites and
outcomes of binding will lead to new inhibitor design studies. Here, utilizing molecular docking with classical and
constant pH molecular dynamics simulations, two novel binding sites for RIM and AMA molecules were revealed. Both
structural and chemical effects of inhibitors on M2 protein on the closed, inactive M2 channel structure were investigated.
Upon binding of the inhibitor molecules, decrease in ion channel cross-distances was observed. Meanwhile, RIM binding
did not alter protonation of His 37s and Asp 44s, whereas AMA binding drastically increased the protonation population
of two residues from different monomers, creating a more basic channel at physiological pH.
Key words: Influenza A M2, ion channel, molecular dynamics simulations, constant pH molecular dynamics simulations,
rimantadine, amantadine

1. Introduction
M2 protein is a homotetramer transmembrane protein, which has a pivotal role in influenza A virus, responsible
for flu. The first 23 amino acids of the N-terminal facilitate binding to the host cell, amino acids 23–46 form the
transmembrane alpha helix that constructs the proton channel, and amino acids located at the C-terminal are
responsible for viral proliferation. 1,2 In the alpha helix region amino acid His 37 acts as a pH sensor and Trp
41 forms the gate of the channel. 3 Additionally, Asp 44 is believed to stabilize Trp 41 through H-bonding. 4,5
Any change in protonation states of amino acids His 37 and Asp 44 upon pH alteration of the environment
is known to destabilize Trp 41 and consequently the ion channel turns into an open conformation. However,
protonation states of His 37 residues are still under debate, and despite numerous experimental and theoretical
studies, protonation states of four His 37s are not clear. 6−10 In 2010, Acharya et al. solved the high resolution
(1.65 Å) X-ray structure of the M2 tetramer and revealed that two of four His 37s were protonated at δ and ε
sites (fully protonated) and two were protonated only at ε sites. 11
There are two commercially available drugs used widely for M2 channel inhibition, rimantadine (RIM)
and amantadine (AMA), drawn in Figure 1. However, in humans, birds, and pigs, drug resistance has reached
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more than 90% recently. 12 In addition, the use of amantadine as an antiinfluenza drug is limited as it displays
nervous system side effects. 13 Thus, active research for designing novel channel inhibitors is underway. AMA
was shown to bind into a hydrophobic pocket consisting of Val 27, Ala 30, and Ser 31 in the X-ray structure by
Stouffer et al, 14 whereas in the NMR structure resolved by Schnell et al., RIM binding pockets were formed by
Leu 40, Trp 41, Ile 42, Leu 43, Asp 44, and Arg 45, located both inside and outside of the channel. 15 There are
numerous studies on the structural effects of AMA and RIM binding to ion channels, which can be found in the
detailed review by Hong and DeGrado. 8 On the other hand, there is a limited number of studies focused on
the alteration of protonation states of His 37 and Asp 44 residues. 16,17 These NMR studies revealed that upon
amantadine binding protonation states of His 37 residues changed, revealing a chemical effect on the proton
channel.

RIM

AMA

Figure 1. 2D drawings of RIM and AMA ligands.

This work will address the structural and chemical effects of inhibitor binding on the inactive closed
conformation M2 protein channel through a plethora of computational calculations. Four binding sites, two
of which were observed for the first time, were revealed and structural alterations were investigated through
molecular docking and classical molecular dynamics (MD) simulations. Then the chemical effects of inhibitor
binding were studied by analyzing the shift in protonation states of His 37 and Asp 44 residues through constant
pH MD simulations. This article is organized in the following manner: binding sites will be discussed together
with structural consequences observed upon binding and chemical effects by alteration in protonation states of
residues His 37 and Asp 44 will be discussed for each type of binding of RIM, followed by AMA.
2. Results and discussion
2.1. Structural effects of RIM binding
Four binding sites were identified for RIM on M2 protein, listed in Table 1. Sites 1 and 2 were located inside
the proton channel, site 3 was located at the bottom of the channel, towards the intracellular space, and site
4 was located outside the channel (Figure 2). Binding site 1 was located just above the pH sensor His 37
residues and consisted of residues Ala 30, Ile 33, and Gly 34. RIM interacted with Ala 30 through H-bonding
between its amine H atoms and backbone O atoms of two of the Ala 30 residues, and side chains of Ile 33
and Gly 34 residues created a hydrophobic cleft for the ligand. Binding energy of the ligand in this binding
site was computed as 41.3 kcal/mol (Table 2). This binding site was also identified in different experimental
and computational studies. 6,15,18 However, in these studies RIM was observed in protonated form, whereas
free binding energies from MD simulations clearly showed that RIM is deprotonated. Detailed discussion of
deprotonation of ligands is provided in Section 2.5. Comparison of intermolecular distances between C α atoms
of amino acid pairs chosen from four different regions of the channel, summarized in Table 3, clearly indicated a
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constricted channel from the Val 27 region upon ligand binding. Changes in distances between two monomers
across the channel were also observed at the His 37 and Lys 49 amino acid regions. Binding site 2 was located
inside the channel, below pH sensor His 37 and channel gate Trp 41 residues. This binding site was the most
frequently detected binding site by RIM, with 53% of total hits, in molecular docking simulations and it is the
first of two novel sites observed in this study. This site was formed by amino acids Asp 44, Phe 47, Phe 48, and
Ile 51. The amine H atom of RIM made an H-bond with the backbone O atom of Asp 44, whereas Phe and Ile
residues created a highly hydrophobic cleft. Binding energy of the ligand in this binding site was computed as
13.5 kcal/mol. The channel distance comparison revealed slight constriction at Trp 41 and Lys 49 regions, but
expansion in other regions of the channel, surprisingly. The reason for this expansion may well be the protein’s
effort to accommodate the ligand inside the channel. Site 3 is the second novel binding site, located at the
bottom of the channel, that has never been observed before. This highly hydrophobic binding pocket consisted
of Ile 51, Phe 55, and Leu 59. One of the amine H atoms formed NH- π interaction with the benzene ring of
one of the Phe 55 residues. Other Phe, Leu, and Ile residues provided a hydrophobic pocket for the ligand.
Binding energy of the ligand in this binding site was computed as 24.4 kcal/mol, which is the second best for
RIM binding. Upon ligand binding two regions of the channel constricted slightly. These regions were the Val
27 region and Lys 49 region, where the ligand was bound. This binding site seems very promising for ligand
binding because it lay at one of the narrowest points of the channel, surrounded by highly hydrophobic Phe
and Leu residues, and highly bulky phenyl rings of Phe residues. Moreover, it was the exit of the channel into
intracellular space. Binding site 4 is the only outside binding pocket obtained in this study. This binding site
was located slightly lower than the binding site observed in the NMR structure by Schnell et al. 15 From docking
simulations the same binding site resolved in the NMR structure was obtained, where the ligand interacted with
residues Ile 42 and Leu 46. However, after classical MD simulations RIM moved slightly down and was stabilized
in this new binding site, which consisted of Phe 47, Phe 48, and Arg 53 residues. In this pocket, the amine
group of RIM formed a very strong H-bond with the HH atom of Arg 53 and side chains of Phe 47 and Phe
48 amino acids formed a highly hydrophobic pocket. Due to its outside position, this binding site was formed
by only one monomer of the M2 tetramer, which explains the lowest binding energy computed for the RIM
ligand, 5.9 kcal/mol (Table 1). Binding of RIM constricted the channel at two regions, Val 27 and His 37. The
Val 27 region was constricted the most among all other RIM binding cases, close to 2 Å on one side and 0.1
Å on the other side. In addition, similar to binding site 1, binding to this site tightened the channel from the
His 37 region, which together with Trp 41 is known to be the channel volume controller. Therefore, binding to
this pocket might have significant functional outcomes, which might require an experimental study. Analysis
of root mean square fluctuation (RMSF) values for individual amino acids indicates significant changes upon
RIM ligand binding. As seen from Figure 3, RIM binding increased RMSF values of the second monomer in
the region between residues Asp 44 and Lys 60. Especially binding to sites 3 and 4 increased RMSF values of
C-terminal residues sharply. Binding to site 4 also increased RMSF values of the third and fourth monomers.
On the contrary, binding of the ligand decreased RMSF values only at the C-terminal of monomer 1 and Asp
44–Ser 50. These simulations demonstrated that ligand binding significantly altered the fluctuation of residues
in this region specifically, which hosts the Asp 44 residue, responsible for channel gating.
2.2. Chemical effects of RIM binding
Chemical effects of ligand binding were analyzed by examining deprotonation populations of His 37 and Asp
44 residues. Deprotonation populations obtained from CPHMD simulations of 5 ns in length were compared
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Table 1. Binding sites for RIM on M2 protein.

Residues

RIM binding free
energy (kcal/mol)

Site 1
Ala 30
Ile 33
Gly 34

Site 2
Asp 44
Phe 47
Phe 48
Ile 51

Site 3
Ile 51
Phe 55
Leu 59

Site 4
Phe 47
Phe 48
Arg 53

41.3

13.5

24.4

5.9

Table 2. Calculated binding free energies for deprotonated and protonated ligands on M2 protein in kcal/mol.

Site
Site
Site
Site

1
2
3
4

Deprotonated
RIM
41.3
13.5
24.4
5.9

Deprotonated
AMA
26.7
16.0
21.4
6.4

Protonated
RIM
23.3
18.4
21.8
12.2

Protonated
AMA
19.7
5.9
17.3
–1.2

R45
F48

Site 1
L46
F54

His 37

3.6

R53

K49

Asp44

H57

Site 4

Site 2

F55

F55
2.5

180°

F55
F55
L51

Site 3

L59

Figure 2. Binding sites for RIM (shown in red) and AMA (shown in yellow) on M2 protein. Novel binding sites (sites
2 and 3) are shown in detail for AMA and RIM, respectively. Site 3 was viewed from the bottom of the protein and the
ion channel can be seen in red frame. H-bond distances in Å are shown in the figure.

for APO and ligand bound M2 structures. As can be seen from Table 4, in the APO M2 structure all His
37 and Asp 44 residues were calculated to be in the deprotonated state. Only the His 37 residue located in
monomer 4 was found to be protonated 0.5% of the time ( +1 state). Although this seems to contradict with
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Table 3. Channel distances in Å between different pairs of residues from each of four monomers upon RIM binding.

Regiona
V271 –V273
V272 –V274
H371 –H373
H372 –H374
W411 –W413
W412 –W414
K491 –K493
K492 –K494

APO
13.4
10.6
12.1
11.7
13.1
14.1
20.7
18.6

Site 1
12.5
10.6
12.0
12.0
13.2
14.5
19.7
19.1

Site 2
13.5
10.6
12.9
11.8
12.7
14.5
20.9
17.7

Site 3
12.1
10.7
12.2
11.9
13.2
14.2
19.7
18.8

Site 4
11.6
10.5
12.3
11.4
13.2
14.1
21.1
19.0

a

Each monomer number is given in subscript. Two distances in each region define the cross-section of the channel in
that region. Val 27 is located at the entrance (top) and Lys 49 at the exit (bottom) of the channel. These regions are
pictured in Figure 9.
APO
Site 1
Root mean square fluctuation (RMSF, Å)

4.0

Site 2
Site 3
Site 4

3.0

Monomer 1

Monomer 2

Monomer 3

Monomer 4

2.0

1.0

0

27 32 37 42 47 52 57 24 29 34 39 44 49 54 59 26 31 36 41 46 51 56 23 28 33 38 43 48 53 58

Residue #

Figure 3. RMSF values for APO and RIM bound M2 proteins.

the experimental +2 state obtained in the high resolution crystal structure (PDB ID: 3BLW),. 11 it should be
recalled that the crystal structure was obtained at pH 6.51, whereas our calculations were performed at pH 7.0.
Where the APO and ligand RIM bound structures are concerned, it should be stated that any change smaller
than 4% in deprotonation percentages reported in Table 4 is not taken as a significant change. Although there
is no reference in the literature for this cut-off value, the high number of small alterations around 1%–2% led us
to believe that the precision of these calculations is below 2%–3%. Thus, in the manuscript only changes above
4% will be discussed. Binding to site 1 did not result in any significant alteration of the protonation state of
His 37 and Asp 44 residues, but only that of the Asp 44 residue in the first monomer, where the deprotonation
population decreased by 4.3%. This was interesting because the binding site was considerably far away from
the Asp 44 residue. Binding to site 2 had no significant effect on deprotonation populations. RIM binding to
site 3 had the highest influence on protonation states. Binding caused a slight reduction of deprotonation of
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His 37 on monomer 3. In contrast, it reduced S deprot of His 37 of monomer 2 by 5.7%. This finding was very
interesting because, although binding site 1 is much closer to the His 37 residues, binding did not affect the
protonation of these residues. This novel binding site also reduced S deprot of Asp 44 of monomer 1 by 5.1%.
RIM binding to this newly identified binding site had the highest chemical impact on M2 protein. Binding to
site 4, the only binding site located outside the channel, did not show any significant alteration for any of the
residues.
Table 4. Deprotonation (S deprot ) populations (%) for each of His 37 and Asp 44 residues for APO and RIM bound M2
proteins.

Residuea
His 371
His 372
His 373
His 374
Asp 441
Asp 442
Asp 443
Asp 444
a

APO
100
100
100
99.5
99.7
99.5
99.4
99.8

Site 1
100
100
100
99.8
95.7
99.8
99.9
100

Site 2
100
100
100
99.1
100
99.1
100
100

Site 3
100
94.3
99.7
100
94.9
99.0
99.9
99.9

Site 4
100
99.7
100
100
99.9
99.7
100
99.8

Each monomer number is given in subscript.

2.3. Structural effects of AMA binding
Similar to RIM binding, four binding sites were identified on M2 protein, listed in Table 5. These sites are
identical to RIM binding sites, sites 1 and 2 located inside the channel, site 3 at the exit of the channel, and
site 4 located outside the channel (Figure 1). At binding site 1, the amine group of the ligand made a strong
H-bond with the HD1 atom of His 37. Residues Ala 30, Ile 33, and Gly 34 created a hydrophobic cleft, which
hosted the hydrophobic part of the ligand. The binding energy of the ligand in this binding site was computed
as 26.7 kcal/mol. AMA binding at this site drastically decreased one of the distances at the Val 27 and Lys
49 regions (1.6 Å and 3.7 Å, respectively), as listed in Table 6. On the contrary, the binding slightly increased
intermolecular distances at the His 37 and Trp 41 regions for both monomer pairs. At binding site 2, one
of the two novel sites, the AMA ligand made two strong H-bonds with the Arg 45 residue from monomer 1.
One of them involved the side chain of the residue and the amino group of AMA, and the other involved the
backbone O of Lys 49 from monomer 4 and the amino group of AMA. Another important interaction is NH- π
interaction between the amino group of AMA and the benzene ring of Phe 54 on monomer 4. Moreover, Phe
48 residues from all monomers created a hydrophobic cleft for the ligand, which was buried in that pocket.
Binding energy of AMA in this binding site was computed as 16.0 kcal/mol (Table 5). Binding at this site
resulted in constriction of one distance at each part of the channel, which was observed for the first time in this
study. Binding site 3, the second novel binding site for AMA, was located at the exit of the channel, towards
the intracellular space. Interactions holding AMA at this binding site are purely hydrophobic. Ile 51, Phe 55,
and Leu 59 residues from each monomer created this highly hydrophobic cleft. Binding energy of the ligand in
this binding site was computed as 21.4 kcal/mol, which is only 5.3 kcal/mol lower than the energy computed
upon binding at site 1. Interestingly, binding to this end of the channel slightly decreased the channel diameter
at the Val 27 region, the entrance of the channel. One distance decreased by 1.8 Å, while the other increased by
340

ÖZBİL/Turk J Chem

0.5 Å. Similarly, a slight decrease of 0.6 Å was observed for the His 37 region. On the other hand, the channel
expanded slightly at the Trp 41 and Lys 49 regions, which was similar to the Trp 41 region expansion also
observed upon ligand binding at site 1 (Table 6). Site 4, similar to binding site 4 for the RIM ligand, which
was the only pocket located outside the channel, possessed a highly hydrophobic character. The AMA ligand
formed H-bonds only with the Arg 53 and His 57 residues. The Phe 48 and Phe 54 residues from monomer 4
created one side of the hydrophobic pocket. The side chain of Leu 46 and long carbon chains of Arg 45 and Lys
49 side chains formed the other side of this highly hydrophobic pocket. This type of hydrophobic interaction
is commonly observed in proteins. 19 Binding energy of the ligand in this binding site was computed as 6.4
kcal/mol, which is the lowest binding energy calculated for the AMA ligand. Binding at this site constricted the
channel at the Val 27 region, decreasing one distance by 2.3 Å and increasing the other by 1.0 Å. Surprisingly,
binding expanded the channel at the Trp 41 region. Distances increased by 0.5 and 0.7 Å, marking a significant
expansion. Moreover, expansion at the end of the channel, at the Lys 49 region, was observed. Binding at site 1
reduced RMSF values of only the C-terminal of monomer 1 compared to APO M2 protein (Figure 4). Binding
increased the RMSF values for almost the entire protein, increasing values extremely for the Phe 47–Lys 60
region of monomer 2. Binding at site 2 affected the RMSF values the most, increasing drastically at the Leu
43–Lys 60 region at monomer 2, the C-terminal having the biggest increment. A similar but smaller increment
in RMSF values at the Asp 44–Lys 60 region of monomer 4 was observed. Binding at site 3 did not lead to any
significant alterations of RMSF values, except for a slight decrease at the C-terminal region of monomer 1 and
significant increase at the C-terminal of monomer 2. Binding to site 4, the outside binding site, did not have a
significant effect on RMSF values. Similar to RIM binding, alteration in the fluctuation of the transmembrane
proton channel might have important functional consequences.
Table 5. Binding sites for AMA on M2 protein.

Residues

AMA binding
free energy
(kcal/mol)

Site 1
Ala 30
Ile 33
Gly 34

Site 2
Arg 45
Phe 48
Phe 54

Site 3
Ile 51
Phe 55
Leu 59

Site 4
Arg 45
Leu 46
Phe 48
Lys 49
Arg 53
Phe 54
His 57

26.7

16.0

21.4

6.4

2.4. Chemical effects of AMA binding
Similar to RIM binding, chemical outcomes of AMA binding on the protein were analyzed by investigating
deprotonation populations of His 37 and Asp 44, shown in Table 7. Where APO and ligand AMA bound
structures are concerned, it should be restated that any change smaller than 4% in deprotonation percentages
reported in Table 7 was not taken as a significant change for the aforementioned reasons. Binding of AMA
at binding site 1 did not change the deprotonation populations of His 37s and Asp 44s significantly. Binding
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Table 6. Channel distances in Å between different pairs of residues from each four monomers upon AMA binding.

Regiona
V271 –V273
V272 –V274
H371 –H373
H372 –H374
W411 –W413
W412 –W414
K491 –K493
K492 –K494

APO
13.4
10.6
12.1
11.7
13.1
14.1
20.7
18.6

Site 1
11.8
15.2
12.6
12.1
13.7
14.2
21.0
14.9

Site 2
12.3
11.0
11.7
12.6
12.9
14.7
21.6
17.7

Site 3
11.6
11.1
11.5
11.9
12.9
14.9
21.6
18.5

Site 4
11.1
11.6
11.8
12.0
13.6
14.8
22.5
18.4

a

Each monomer number is given in subscript. Two distances in each region define the cross-section of the channel in
that region. Val 27 is located at the entrance (top) and Lys 49 at the exit (bottom) of the channel. These regions are
pictured in Figure 9.
9.0

Root mean square fluctuation (RMSF, Å)

APO
Site 1

8.0

Site 2
7.0

Site 3
Site 4

6.0

Monomer 1

Monomer 2

Monomer 3

Monomer 4

5.0

4.0

3.0

2.0

1.0

0

27 32 37 42 47 52 57 24 29 34 39 44 49 54 59 26 31 36 41 46 51 56 23 28 33 38 43 48 53 58

Residue #

Figure 4. RMSF values for APO and AMA bound M2 proteins.

at site 2 affected protonation states of all His 37 and Asp 44 amino acids, demonstrating the most dramatic
alterations observed for both ligands. Deprotonation of His 37 at monomer 2 by 17.4% was the highest change
upon ligand binding in the current study. This binding mode of the AMA ligand clearly increased protonation of
this particular His 37 and slightly Asp 44 at monomer 2 by 2.0%, which clearly changed the chemical identity of
the channel, creating a tunnel with more basic character. Binding at site 3 slightly decreased the deprotonation
populations of Asp 44 at monomer 1 by 3.2% and at monomer 2 by 1.2%, which are not very significant changes
and are below the 4.0% alteration cut-off applied in this study (Table 7). Binding at site 4 resulted in the second
biggest alterations after binding at site 2. Protonation populations of His 37s remained the same, while the
deprotonation population observed for Asp 44 at monomer 1 decreased by 14.2%. This was the second highest
alteration of protonation state observed in the study. Deprotonation to 85.8%, or in other words protonation
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to 14.2%, revealed significant basicity for this Asp 44 amino acid. The change in protonation states might be
a result of proton transfer between M2 amino acids and water molecules located nearby, observed in the most
representative structures from MD simulations.
Table 7. Deprotonation (S deprot ) populations (%) for each His 37 and Asp 44 residue for APO and AMA bound M2
proteins.

Residuea
His 371
His 372
His 373
His 374
Asp 441
Asp 442
Asp 443
Asp 444
a

APO
100
100
100
99.5
99.7
99.5
99.4
99.8

Site 1
100
99.9
100
100
99.7
99.4
100
98.0

Site 2
99.3
82.6
98.1
99.6
99.6
98.0
99.9
99.7

Site 3
99.7
100
100
99.9
96.8
98.8
99.7
99.5

Site 4
100
100
99.9
100
85.8
99.6
100
99.7

Each monomer number is given in subscript.

2.5. Docking simulations of protonated ligands on M2 protein
As ligands have high pKa values (for amantadine pKa = 9), 20 protonated RIM and AMA ligands (bearing +1
charge with NH +
3 group) were docked on M2 protein. Similar binding sites were observed with differences in
ligand orientations. This resulted in a slight decrease in binding affinities obtained by AutoDock Vina, around
0.2 kcal/mol. However, upon calculation of free binding energies with MD simulations of 500 ps, drastic changes
were observed. Binding free energies, provided in Table 2, clearly decreased for AMA and in two cases for RIM.
These changes in binding energies were due to the change in hydrophobic interactions and the new dominance
of electrostatic interactions created by the NH +
3 group (Figure 5). Only the RIM ligand bound in sites 2 and
4 showed a significant increase in binding energies, 4.9 kcal/mol and 6.3 kcal/mol, respectively. However, it is
very hard to rule out protonated forms of ligands in general, except RIM binding into site 1 and AMA binding
into site 2. In these two cases of deprotonated ligands the binding free energy differences clearly favored the
protonated form of ligands. It is noteworthy that the sum of the binding energy and deprotonation energy
determines the protonation state of the binding ligand. As mentioned above, both ligands have high pKa values
and are expected to be protonated in bulk water. Thus, free energy of deprotonation cost will be around 5–10
kcal/mol. In addition, error of margin in binding free energy calculations, 1–2 kcal/mol, must be taken into
account. As a result, according to the calculated binding energies in Table 2, it is very hard to decide which
form of ligands will bind dominantly. Moreover, calculated binding free energies were higher for protonated
RIM into binding site 2. Chew et al. also studied protonation/deprotonation of adamantane ligands in a lipid
layer. 20 They concluded that membrane-permeant ligands must be in deprotonated form. However, the exact
time of deprotonation of the ligands, whether in bulk solution or upon absorption into the lipid layer, was not
clearly known.
2.6. Conclusions
Elevated drug resistance of M2 protein towards inhibitors inspired recent pharmaceutical research to design more
potent inhibitors than the already available inhibitors, RIM and AMA. The main strategy focuses on blocking
343
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B

A

Ala 30

Ala 30

Ile 33
Ile 33
Figure 5. A) Orientations of deprotonated ligands, B) orientations of protonated ligands. RIM is shown in red and
AMA is shown in yellow.

the ion channel, either by directly blocking it or constricting it through an allosteric pathway. However, the
exact mechanisms of action of these inhibitors are not well understood yet. In this study, first the binding sites of
RIM and AMA were searched through tandem molecular docking and classical molecular dynamics studies. For
this purpose, both deprotonated and protonated forms of the ligands were studied on the high pH, inactivated
conformation of the M2 channel. All binding sites consisted of mainly hydrophobic residues, which resided in the
common adamantane part of the inhibitor molecules, three connected cyclohexane rings in chair configuration.
Apart from confirming the already observed binding sites, two novel binding sites for each inhibitor molecule
were elucidated. These sites, sites 2 and 3, were located at the exit of the channel and outside of the channel,
respectively. Computed binding energies revealed that both ligands were bound to the protein in binding sites
1 and 3 more tightly than in binding sites 2 and 4. When compared with protonated ligands, deprotonated
ligands had significantly higher binding free energies, except for RIM binding at sites 2 and 4. The reason for
this was the dominance of hydrophobic interactions, especially for RIM, the CH 3 group next to the amine group.
Protonation of the amine group shields this methyl group; thus, RIM cannot interact with M2 through strong
hydrophobic interactions. Moreover, RIM was reported to bind into site 1 as a deprotonated ligand in this
study, to our knowledge for the first time in the literature. Moreover, it was obvious that AMA binds into site
2 in the deprotonated state as well. For other binding sites, it was very hard to clearly state which protonation
forms of ligands were dominant. The reason for that is the small free binding energy difference, ranging from
2.6 kcal/mol to 7.6 kcal/mol, which might be the consequence of deprotonation free energy of ligands and
calculation error. Structural analysis in the study also revealed that binding of both inhibitor molecules on
site 1 and site 3 either decreased or retained channel width. After identifying the precise inhibitor binding
sites, chemical effects of binding were investigated. By utilizing constant pH molecular dynamics simulations,
alteration of protonation states for residues His 37 and Asp 44 upon binding were investigated. His 37s are
known to act as a pH sensor of this channel, and Asp 44s together with Trp 41s are the gates of the channel.
Binding of RIM did not alter protonation states of His37s and Asp44s significantly. However, AMA altered the
protonation states of these two residues, proving the chemical effect of inhibitor binding. Especially binding of
AMA at binding sites 2 and 4 increased protonation of these two residues, by 17.4% and 14.2%, respectively.
Increased protonation means increased basic character for the channel, which is just the opposite of the high
acidity required for the virus. This study revealed precise binding sites for two commercially available inhibitor
molecules for the M2 protein channel of influenza A virus, including two novel binding sites. Between these two
novel binding sites, site 3 proved to be a better candidate for both RIM and AMA ligands with higher binding
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affinity and better channel width retention or constriction. In addition, chemical effects of the inhibitors on the
channel’s protonation were elucidated, which will guide future inhibitor design studies.
3. Experimental
3.1. Classical molecular dynamics simulations
All classical MD simulations were performed using the GROMACS 5.0.0 program, 21−23 which was utilized with
GROMOS force field GROMOS96 53A6. 24 Initial coordinates for the M2 protein channel region were taken
from solution NMR structure (PDB ID: 2KIH). 25 In this structure, the Ser 31 residue was mutated to Asn; thus,
it was mutated back to Ser by utilizing VMD 1.9.1 software. 26 The ligand-free M2 protein was embedded into
a DPPC (dipalmitoyl phosphatidylcholine) membrane model. 27 Later, the system was placed in a truncated
rectangular box with dimensions of 6.2 × 6.2 × 10.6 nm. These dimensions ensured that at any point of the
simulation the proteins stayed in the simulation box. The box was filled with single point charge (SPC) water
molecules. 28 and some of them were displaced during the addition of chloride ions to neutralize the system,
visualized in Figure 6.

A

B
His37
Asp44

Figure 6. A) System that was utilized in classical MD simulations. M2 protein was embedded in DPPC lipid bilayer
and this complex was put into simulation box and filled with SPC water molecules. B) Zoomed in view of M2 protein,
each monomer shown with a different color. Titratable His 37 and Asp 44 residues are shown with stick representation.

Starting structures were subsequently energy-minimized using the steepest descent method for 50,000
steps. Energy-minimized structures were taken for the production phase. MD simulations without any constraints were carried out using a constant number of particles (N), pressure (P), and temperature (T), i.e. NPT
ensemble, which is slightly above the phase transition temperature of the DPPC lipid layer. The SETTLE
algorithm was used to constrain the bond length and bond angle of the water molecules,. 29 while the LINCS
algorithm was used to constrain the bond length of the peptide. 30 Long-range electrostatic interactions were
calculated by the particle-mesh Ewald method. 31 A constant pressure of 1 bar was applied with a coupling
constant of 1.0 ps and water molecules/chloride ions were coupled separately to a bath at 323 K with a coupling
constant of 0.1 ps. This temperature was above the phase transition temperature of DPPC. The equation of
motion was integrated at 2 fs time steps using a leap-frog algorithm. 32 The tools available in the GROMACS
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program package and VMD software were used to analyze the MD trajectories. Structures of ligands were
optimized by using YASARA software with YAMBER force field. 33,34 Parameters for the ligands, RIM and
AMA, were obtained from the PRODRG server. 35
The production run for ligand-free (APO) M2 protein lasted for 50 ns. MD simulations of ligands in
different binding pockets, obtained from molecular docking simulations, were run for 20 ns to ensure the stability
of ligands in the binding pockets. Root mean square deviation (RMSD) graphs for RIM and AMA ligands in
binding pockets, which revealed stable binding of the ligands, are provided in Figures 7 and 8, respectively.
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Figure 7. RMSD values for RIM ligands bound at each binding site. RMSD values lower than 3.0 Å and straight graphs
proved that ligands were stable at binding sites.
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Figure 8. RMSD values for AMA ligands bound at each binding site. RMSD values lower than 3.0 Å and straight
graphs proved that ligands were stable at binding sites.

Ligand binding energies were calculated by utilizing YASARA Dynamics md_analyzebindingenergy
macro. 36 In order to use this module, MD simulations of 500 ps long were run with the same parameters
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Figure 9. Four different regions, Val 27, His 37, Trp 41, and Lys 49, where distances between C α atoms were calculated
and are provided in Table 3 and Table 6. These distances reveal the channel diameter for different regions of the channel.

utilized in production runs. Ligands were found to be stable in their binding sites. As details can be found in
the YASARA manual, this module calculates free energy without the entropy term from normal mode analysis.
G = Ebind + Eel + EvdW + Gpolar + Gnonpolar − T S

(1)

Here, the first three terms are molecular mechanics (MM) terms of binding, electrostatic, and van der Waals
interactions, respectively. G polar and G nonpolar are polar and nonpolar contributions of solvation free energies,
respectively. TS is the entropy effect, which is neglected. Then binding free energy is calculated by the following
equation.
Binding energy = (GReceptor + GLigand ) + (GsolvReceptor + GsolvLigand ) − (GComplex + GsolvComplex ) (2)
Here, the first two terms are potential energies of the receptor and ligand, the next two terms are solvation
energies of the receptor and ligand, and the last terms are potential and solvation energies of the complex.
YASARA, as explained in its manual, provides positive binding energies (http://www.yasara.org/macros.htm).
A more positive value indicates a better binding, whereas a negative number indicates very weak binding, but
not nonbinding. Similar data utilizing YASARA can also be found in the studies by Dulebo et al. 37 and Ozalp
et al. 38
Thus, it is very similar to the MM/PBSA method, 39,40 except for the entropy term, which can be
neglected in the context of the main goal of these calculations, where we compare ligand binding affinities for
the same ligand in different binding sites and any error will be carried through all numbers.
3.2. Constant pH MD simulations
In classical MD simulations, protonation states of titratable amino acids are predetermined. However, in
constant pH MD (CPHMD) simulations, the pH of the environment is kept fixed and predefined titratable
amino acids are allowed to change their protonation states according to alteration in the microenvironment.
There are many models nowadays to choose from for CPHMD simulations; in this study, the method by
Donnini et al. was chosen. 41 All free energy and CPHMD calculations were done utilizing the GROMACS
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implementation GROMACS 3.3.3-CPHMD. This method will be briefly described now. First, the deprotonation
free energy of each individual amino acid was calculated. In this study, deprotonation free energies of His
and Asp amino acids that lay in the proton channel formed by four monomers were calculated by utilizing
a thermodynamic integration method. 42 For the His residue, only one protonation site, the NE2 atom, was
allowed to change its protonation state. Although theoretically there can be four different protonation states,
protonation/deprotonation of the NE2 atom are the most commonly observed states for His amino acid in large
proteins in biological systems. 43 For the Asp residue, only the OD2 atom was allowed to change its protonation
state. Again, four different protonation states were possible, but in this study only OD2 was chosen to change
its protonation state because of its proximity to neighboring Arg amino acid, which should affect its protonation
state. These energies were in agreement with experimental values, 44,45 which confirmed the method used, and
are shown in Table 8. Then these energies were included in the Hamiltonian of the λ -particle system, whose
Hamiltonian was defined as:
Table 8. Calculated deprotonation free energies for free His, Asp, and Glu amino acids in water together with comparison
of calculated and experimental pK a values.

Amino acid
His-NE
His-ND
Asp
Glu

Calculated deprotonation
free energy (kcal/mol)
32.09
37.79
–63.51
–53.68

Reference pK a

Calculated pK a

6.53
6.92
3.94
4.25

6.52
6.94
5.12
4.50

H (λ) = (1 − λ) H0 + λ H1 + HEnv +

m 2
λ +U ∗ (λ),
2

(3)

and V( λ) , the potential energy part of the Hamiltonian, was defined as:
V (λ) = (1 − λ) V 0 + λ V 1 + V Env +U ∗ (λ).

(4)

λ was allowed to change between 0 and 1, defining protonated and deprotonated states, respectively. Upon
calculating free energies of protonation, pKa values of free His and Asp amino acids were calculated through
titration experiments at pH values ranging from 1.0 to 7.0. For each amino acid the fraction of deprotonated
acid (S deprot ) was calculated, and the Henderson–Hasselbalch equation was fitted to the obtained titration
curve:
1
.
(5)
S deprot = (pKa−pH)
10
+1
The fraction of deprotonated states was calculated from λ values; steps with λ > 0.9 were counted as
deprotonated while steps with λ < 0.1 were counted as protonated. Then this graph was fitted and the
pH value at which S deprot was 0.5 was taken as pKa. To validate these calculations, pKa values for free His and
Asp residues as well as His and Asp residues in hen egg-white lysozyme (HEWL), which was widely accepted as
a reference system for pKa calculations, 46,47 were calculated. Calculations on HEWL were made on the X-ray
structure by Walsh et al. (PDB ID: 4LZT). 48 Computed pKa values for free amino acids and residues in HEWL
protein were within ± 1 pKa value error interval compared to experimental values and are shown in Table 9.
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These calculations validated the method used in this study. For ligand-free M2 protein calculations, the most
representative structure was obtained from classical MD simulations of 50 ns and pKa values for each of four
His 37 and Asp 44 residues were calculated. Table 10 shows these values. For His 37 residues on monomers
1 and 3, pKa values could not be calculated, owing to pKa values of < 0.1. For monomers 2 and 4 extremely
low values of 0.66 and 1.06 were calculated, respectively. Although these values are low for His residues, they
reveal that the protein is in the deprotonated 0 state. Here it should be mentioned that this study deals with
the closed (inactive) state of the proton channel. Thus, His residues are less exposed to solvent and their more
likely protonated states could not be sampled. In the constant pH MD method applied in this study, it is stated
by the developers that even with the biasing potential applied, only one protonation state can be sampled more
dominantly for His. 41 For Asp 44 residues the protonation/deprotonation picture was more clear and all pKa
values were similar, and all Asp residues were clearly in the deprotonated state. For ligand (RIM and AMA)bound M2 protein calculations, the most representative structures from classical MD simulations of 20 ns with
ligands bound on the corresponding binding pockets were utilized. Proteins were placed in rectangular water
boxes with dimensions of 5.0 × 6.0 × 8.2 nm, which were filled with SPC water molecules. Parameters were kept
the same as in classical MD simulations, which were described thoroughly in the previous section. Temperature
was set to 300 K. For M2 proteins, S deprot for each His 37 and Asp 44 were calculated at physiological pH 7.0.
S deprot values were given in percentages as the ratio of deprotonated states to total number of states.
Table 9. Comparison of experimental and calculated pK a values for His 15 and Asp 18 residues in HEWL protein.

Amino acid
His 15
Asp 18

Reference pK a
5.36
2.66

Calculated pK a
4.60
1.92

Table 10. Calculated pK a values for His 37 and Asp 44 residues in M2 protein.

Residue
His 371
His 372
His 373
His 374

pK a value
NA
0.66
NA
1.06

Residue
Asp 441
Asp 442
Asp 443
Asp 444

pK a value
2.96
3.39
2.80
3.29

3.3. Molecular docking simulations
All docking simulations were performed utilizing AutoDock Vina 1.1.2 software. 49 M2 protein structures were
obtained by taking snapshots of each 1 ns of the last 20 ns of classical MD simulations of ligand-free M2
protein. Twenty protein structures were put into a grid box to occupy the whole ligand–M2 protein system
and the spacing was kept at 1.00 Å, a standard value for AutoDock Vina. Each docking trial produced 20
poses with the exhaustiveness value of 20. Rigid docking with this methodology made sure that flexibility of
protein side chains were included in docking simulations, which was performed previously by the author. 50
Structures of ligands were optimized by using YASARA software with YAMBER force field. 33,34 Binding poses
were clustered and four binding pockets for each ligand were assessed. Criteria for clusters were bearing the
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highest binding affinity and the highest population of hits. Docking simulations for each ligand were repeated
twice as AutoDock Vina uses a stochastic optimization algorithm. These repeated simulations produced very
similar binding results with very similar binding affinities.
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